Skip to main
PAYS

PaySign Inc (PAYS) Stock Forecast & Price Target

PaySign Inc (PAYS) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PaySign is a rapidly growing payment processing and prepaid card company, evidenced by its strong 2Q results with 48% revenue growth and 113% increase in adjusted EBITDA. The company's focus on pharmaceutical and healthcare industries, strong financial position, and recent acquisition of Gamma contribute to its positive outlook, although competition and regulatory compliance remain concerns. With plans for international expansion and development of patient affordability programs, Paysign has the potential for continued success and diversification.

Bears say

PaySign is facing several risks as a niche payment solutions provider, including a competitive market dominated by larger competitors, potential regulatory changes that could affect their operations, reliance on a small number of bank partners, and concentration in the plasma donor compensation niche. Additionally, the company's insider ownership and low float may lead to higher share price volatility. While their financials have been strong, particularly in the pharmaceutical segment, there may be challenges in maintaining and growing market share.

PaySign Inc (PAYS) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PaySign Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PaySign Inc (PAYS) Forecast

Analysts have given PaySign Inc (PAYS) a Strong Buy based on their latest research and market trends.

According to 2 analysts, PaySign Inc (PAYS) has a Strong Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PaySign Inc (PAYS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.